BMRN endpoints article.revisiting KOL comments on BMRN bleed free vs. FVIII % data | SGMO Message Board Posts


Sangamo Therapeutics, Inc.

  SGMO website

SGMO   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board
Msg  168017 of 168906  at  10/1/2022 5:13:49 PM  by

ZFP


 In response to msg 168015 by  Watsonncrick
view thread

Re:BMRN endpoints article.revisiting KOL comments on BMRN bleed free vs. FVIII % data

Again worth noting the actual preliminary BioMarin treated ABR data presented at JPM 2020. Pg 12-13 shows 3 participants with more than 10 infusions post Valrox but because of n=16 they could position this as 100% reduction in median treated bleeds and 96% reduction of mean treated ABR.

https://investors.biomarin.com/events-presentations?item=69


     e-mail to a friend      printer-friendly     add to library      
|  
Recs: 9  
   Views: 0 []
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board

Replies
Msg # Subject Author Recs Date Posted
168020 Re:BMRN endpoints article.revisiting KOL comments on BMRN bleed free vs. FVIII % data Watsonncrick 8 10/2/2022 7:53:52 AM




Financial Market Data provided by
.
Loading...